Hence, we suspected that whether circATIC regulated RCC2 expression to promote DDP resistance in BLca cells and constructed DDP-resistant BLca cell lines (5637 DDP and SW780 DDP) in vitro (Fig. 8A). This evidence concerns the gene RCC2 and bladder transitional cell carcinoma.